Literature DB >> 11678159

Subnormal visual acuity syndromes (SVAS): albinism in Swedish 12-13-year-old children.

A Sjöström1, M Kraemer, J Ohlsson, G Villarreal.   

Abstract

BACKGROUND: The vision of 12-13-year-olds in Sweden was examined in a field study. The study was designed as being a part of a large European-Latin American study, the DESAMI project. The objective was to evaluate the prevalence of residual amblyopia and ocular disorders, atiologies of subnormal vision and some normal visual parameters in this group of children. The children had to be born in Sweden in 1985 in order to have the opportunity to be included in the voluntary screening visual examinations. The full results of the study will be presented elsewhere. This paper presents clinical and VEP data of those children who had visual acuity of 0.8 or below in one or both eyes which could not be increased with glasses, or other visual/eye disturbances not explained as common amblyopia, i.e., subnormal visual acuity or pathological visual states of unknown cause, SVAS (subnormal visual acuity syndromes). SUBJECTS AND METHODS: In all, 1046 children were examined: 76 had visual disturbances of such severity that they were referred to a paediatric ophthalmologist (AS). Eighteen children could not be pathologically classified, and they were referred to another ophthalmological examination and VEP (visual evoked potential) recordings. VEP reveals an asymmetric response after monocular stimulation in albinism.
RESULTS: Twelve children turned up for a second examination and VEP was recorded from 10 children. Nine children showed iris translucency. Seven children showed an asymmetric VEP and were classified as albinos. The albinoic VEPs could be subdivided into two types, (1) including all parts of the response and (2) partly excluding the P1/P100 potential complex. The VEP response was normal, showing symmetry and no other abnormality, in three of the children.
CONCLUSIONS: The results indicate that albinism is common in Sweden. A prevalence value of approximately 1% is about 100 times higher than previous figures. This high prevalence may indicate another form of heredity, with genetical contribution to albinism from a varying number of albino genes and varying expression in the phenotypes, in the Scandinavian population. It is emphasised that in investigations of children with SVAS, electrophysiological examinations are important, not only to reveal albinism but also to exclude or verify neurometabolic conditions, for example.

Entities:  

Mesh:

Year:  2001        PMID: 11678159

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  21 in total

1.  Visual resolution limits in human albinism.

Authors:  R V Abadi; E Pascal
Journal:  Vision Res       Date:  1991       Impact factor: 1.886

2.  Transillumination of iris and subnormal visual acuity--ocular albinism?

Authors:  L Sjödell; A Sjöström; M Abrahamsson
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

3.  Functional development of the visual system in normal and protein-deprived rats. V. Specific cortical response and repetitive stimulation in adult rats.

Authors:  A Sjöström; N G Conradi; S A Andersson
Journal:  Acta Physiol Scand       Date:  1987-08

4.  Asymmetric visually evoked potentials in human albinos: evidence for visual system anomalies.

Authors:  D Creel; C J Witkop; R A King
Journal:  Invest Ophthalmol       Date:  1974-06

5.  Albinism: phenotype or genotype?

Authors:  D B van Dorp; N J van Haeringen; J W Delleman; P Apkarian; W Westerhof
Journal:  Doc Ophthalmol       Date:  1983-12-15       Impact factor: 2.379

6.  Myopisation: the refractive tendency in teenagers. Prevalence of myopia among young teenagers in Sweden.

Authors:  M G Villarreal; J Ohlsson; M Abrahamsson; A Sjöstrom; J Sjöstrand
Journal:  Acta Ophthalmol Scand       Date:  2000-04

7.  The neonatal development of the light flash visual evoked potential.

Authors:  M Kraemer; M Abrahamsson; A Sjöström
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

8.  Hereditary disease as a cause of childhood blindness: regional variation. Results of blind school studies undertaken in countries of Latin America, Asia and Africa.

Authors:  C Gilbert; J Rahi; M Eckstein; A Foster
Journal:  Ophthalmic Genet       Date:  1995-03       Impact factor: 1.803

9.  Delayed visual maturation. A longitudinal clinical and electrophysiological assessment.

Authors:  S R Lambert; A Kriss; D Taylor
Journal:  Ophthalmology       Date:  1989-04       Impact factor: 12.079

10.  The light-flash-evoked response as a possible indicator of increased intracranial pressure in hydrocephalus.

Authors:  A Sjöström; P Uvebrant; A Roos
Journal:  Childs Nerv Syst       Date:  1995-07       Impact factor: 1.475

View more
  3 in total

1.  Visual evoked potential importance in the complex mechanism of amblyopia.

Authors:  Regina Halfeld Furtado de Mendonça; Stefania Abbruzzese; Bruna Bagolini; Italo Nofroni; Eliana Lucia Ferreira; James Vernon Odom
Journal:  Int Ophthalmol       Date:  2013-02-16       Impact factor: 2.031

2.  A pathogenic haplotype, common in Europeans, causes autosomal recessive albinism and uncovers missing heritability in OCA1.

Authors:  Karen Grønskov; Cathrine Jespersgaard; Gitte Hoffmann Bruun; Pernille Harris; Karen Brøndum-Nielsen; Brage S Andresen; Thomas Rosenberg
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 3.  Recessive mutations in SLC38A8 cause foveal hypoplasia and optic nerve misrouting without albinism.

Authors:  James A Poulter; Musallam Al-Araimi; Ivan Conte; Maria M van Genderen; Eamonn Sheridan; Ian M Carr; David A Parry; Mike Shires; Sabrina Carrella; John Bradbury; Kamron Khan; Phillis Lakeman; Panagiotis I Sergouniotis; Andrew R Webster; Anthony T Moore; Bishwanath Pal; Moin D Mohamed; Anandula Venkataramana; Vedam Ramprasad; Rohit Shetty; Murugan Saktivel; Govindasamy Kumaramanickavel; Alex Tan; David A Mackey; Alex W Hewitt; Sandro Banfi; Manir Ali; Chris F Inglehearn; Carmel Toomes
Journal:  Am J Hum Genet       Date:  2013-11-27       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.